Drug Search Results
More Filters [+]

Obinepitide

Alternative Names: obinepitide
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: PYY Analogue,NPY4 Agonist,NPY2 Agonist

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: 7TM Pharma A/S
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Obinepitide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Obesity

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2007-000993-22

P2

Completed

Obesity

2007-10-30

Recent News Events

Date

Type

Title